Results · Apr-Jun 2026
Nephrocare Health Services Q1 FY27 results
Sales grew 24% to ₹282 crore from ₹228 crore in Apr-Jun 2025.
Operating profit was ₹63.9 crore, an operating margin of 22.7%.
Net profit grew 35% to ₹32 crore from ₹23.7 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +6%, net profit +5%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 281.8 | 227.8 | +24% |
| Operating profit (EBITDA) | 63.9 | - | - |
| Operating margin | 22.7% | - | - |
| Net profit | 32.0 | 23.7 | +35% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 4 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.